

Researchers often evaluate tumors over several phases of their life cycle to determine the pathological stepwise progression from early to metastatic disease. Using this methodology, Guidi and colleagues hypothesized that the pattern of angiogenesis would differ from early- to late-stage breast tumors. In an assessment of 110 breast cancer patients (47 with primary tumors and 91 with metastatic axillary lymph nodes), the presence of microvascular "hot spots" in lymph node metastases (but not in primary tumors) was a significant predictor of disease-free survival (P=0.006) and overall survival (P=0.004).19 This suggests that metastatic tumors may have different angiogenic properties and behavior than primary tumors.19,20